Yoshino, J., Mills, K
But some patients develop persistent gastroparesis-like symptoms that don't resolve
Providers typically recommend waiting for robust human efficacy data before considering it a standard treatment
References: Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A
It does not interact with GLP-1 receptors, does not slow gastric emptying, and has no effect on hunger or satiety signals in the brain
Who Tends to Be a Candidate Often a good fit Adults bothered by dullness, uneven tone, or superficial discoloration Patients with melasma-prone skin looking for a barrier-conscious option inside a broader plan Anyone willing to commit to daily sun protection genuinely the deciding factor in pigment work People who want gradual complexion refinement rather than an aggressive resurfacing approach Talk with us first Pregnant or breastfeeding patients elective treatments are typically deferred, and pregnancy-related melasma often changes on its own Anyone with a personal or family history of clotting disorders, or taking hormonal or blood-thinning medication relevant to how tranexamic acid is used Active infection, cold sores, or an inflammatory skin flare in the treatment area Allergies, including sensitivity to marine- or salmon-derived ingredients found in many polynucleotide formulas A history of keloids, recent procedures, or any new or changing spot that needs medical evaluation first Candidacy including whether tranexamic acid is appropriate for you and how it would be delivered is confirmed in person by your provider, never by a web page
